GeoVax Labs, Inc. (GOVX)

US — Healthcare Sector
Peers: SONN  PALI  DRUG  VRAX  TNXP  APDN  ADTX  SIGA  AEMD 

Automate Your Wheel Strategy on GOVX

With Tiblio's Option Bot, you can configure your own wheel strategy including GOVX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol GOVX
  • Rev/Share 0.3445
  • Book/Share 0.1837
  • PB 4.1175
  • Debt/Equity 0.0
  • CurrentRatio 2.0305
  • ROIC -8.8697

 

  • MktCap 19179465.0
  • FreeCF/Share -1.7821
  • PFCF -0.7007
  • PE -0.4683
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -4.088

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Reiterated GOVX Alliance Global Partners -- Buy $15 $8.5 April 15, 2025
Reiterated GOVX D. Boral Capital -- Buy $18 $14 April 15, 2025

News

About GeoVax Labs, Inc. (GOVX)

  • IPO Date 2020-09-25
  • Website https://www.geovax.com
  • Industry Biotechnology
  • CEO David Alan Dodd
  • Employees 17
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.